• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Paratek Pharmaceuticals

Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand
Pharma

Paratek buys Optinose, rhinosinusitis spray Xhance for up to $330M

In a move to expand its portfolio beyond antibiotics, Paratek has bought out Optinose and its chronic rhinosinusitis nasal spray Xhance for $330M.
Kevin Dunleavy Mar 20, 2025 11:23am
Nuzyra bottle and pills

Paratek's pneumonia antibiotic Nuzyra clinches trial win

Jul 19, 2024 8:28am
Nuzyra bottle and pills

Paratek's $462M sale under threat from investor NexPoint

Jun 28, 2023 2:03pm
Photo of two hands shaking

Paratek bought by Novo Holdings, Gurnet Point for $462M

Jun 6, 2023 4:21pm
American flag

What will become of Trump's 'onshore' drug production effort?

Dec 22, 2020 3:00am
Grand River Aseptic Manufacturing

Michigan CDMO builds new plant to meet U.S.-made drug demand

Jun 30, 2020 9:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings